Follow The Filings

MAZE Maze Therapeutics

Maze Therapeutics earnings company data as of 11:56 AM ET 11/17

  • 0 of 1 EPS beats

History

1 period, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS -0.75 -0.79 Miss
Rev — — —

Insider trades

Open-market buys and sales by MAZE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All MAZE insider trades
  • None no insider bought on the open market
  • $1.1M sold by 1 insider outside a trading plan
  • $22.7M sold by 4 insiders under 10b5-1 plans
  1. Jason V. Coloma CEO
    Planned sale
    $1M 34,501 shares at $30.25 16% of stake
    Traded Nov 2 Filed Nov 4
  2. Atul Dandekar Csbo
    Planned sale
    $241K 7,500 shares at $32.07 19% of stake
    Traded Oct 29 Filed Oct 30
  3. Harold Bernstein President, R&D & CMO
    Planned sale
    $435K 16,141 shares at $26.93 100% of stake
    Traded Oct 1 Filed Oct 2
  4. Jason V. Coloma CEO
    Planned sale
    $932K 34,501 shares at $27.02 15% of stake
    Traded Oct 1 Filed Oct 2
  5. Atul Dandekar Csbo
    Planned sale
    $203K 7,500 shares at $27.06 19% of stake
    Traded Sep 29 Filed Oct 1
  6. Harold Bernstein President, R&D & CMO
    Planned sale
    $255K 9,705 shares at $26.22 100% of stake
    Traded Sep 4 Filed Sep 8
  7. Harold Bernstein President, R&D & CMO
    Planned sale
    $426K 16,141 shares at $26.36 100% of stake
    Traded Sep 1 Filed Sep 3
  8. Jason V. Coloma CEO
    Planned sale
    $907K 34,501 shares at $26.29 13% of stake
    Traded Sep 1 Filed Sep 3
  9. Atul Dandekar Csbo
    Planned sale
    $207K 7,500 shares at $27.58 22% of stake
    Traded Aug 28 Filed Aug 31
  10. Harold Bernstein President, R&D & CMO
    Planned sale
    $446K 16,142 shares at $27.61 100% of stake
    Traded Aug 13 Filed Aug 14
  11. Jason V. Coloma CEO
    Planned sale
    $922K 34,501 shares at $26.73 12% of stake
    Traded Aug 3 Filed Aug 5
  12. Atul Dandekar Csbo
    Planned sale
    $205K 7,500 shares at $27.34 22% of stake
    Traded Jul 29 Filed Jul 31
  13. Harold Bernstein President, R&D & CMO
    Planned sale
    $437K 14,609 shares at $29.90 100% of stake
    Traded Jul 1 Filed Jul 2
  14. Jason V. Coloma CEO
    Planned sale
    $1M 34,501 shares at $29.98 11% of stake
    Traded Jul 1 Filed Jul 2
  15. Atul Dandekar Csbo
    Planned sale
    $210K 7,500 shares at $28.02 22% of stake
    Traded Jun 29 Filed Jul 1

Also filed in the last 12 months, not counted as buying or selling: 49 option exercises, 16 sales to cover taxes, and 1 gift.

SEC filings

Recent issuer filings from EDGAR, 10 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
10-Q
8-K 2.02,9.01
8-K 1.01,3.02,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
8-K 2.02,9.01
10-Q
SCHEDULE 13G —
8-K 5.07

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.

Further reading

As an Amazon Associate, FollowTheFilings earns from qualifying purchases.

More on the shelf